Semaglutide 2mg – Ozempic – Fat-Burning Peptide
Semaglutide 2mg – Ozempic
Composition: semiglutide 2 mg
Category: Peptide
Indication: Body weight control and appetite modulation
Dosage form: Vial containing 2 mg of lyophilized powder with a separate 1-mL vial of water for injection, intended for reconstitution
Route of administration: Subcutaneous injection
- Shipping (if the product is in stock): 3 business days for processing and 5 to 20 business days for shipping
- Processing and shipping costs: €27 throughout Italy
What is Ozempic (Semaglutide)?
Ozempic is a medication containing semaglutide, a peptide-based GLP-1 receptor agonist, developed for the treatment of type 2 diabetes and now widely used for weight management and metabolic health as well.
Semiglutide works by mimicking the intestinal hormone GLP-1, which is responsible for regulating satiety, appetite, and blood sugar control. Through this mechanism, Ozempic effectively reduces hunger and promotes gradual, sustainable weight loss.
Main effects of Ozempic (Semaglutide)
🍽 Appetite Control
Semaglutide reduces hunger signals in the central nervous system and slows gastric emptying, prolonging the feeling of fullness after meals.
🩸 Blood Sugar Control
Ozempic stimulates insulin secretion in response to meals and reduces glucagon release, helping to stabilize blood sugar levels, especially in cases of insulin resistance.
⚖️ Weight Loss
By reducing calorie intake and improving appetite control, Semaglutide promotes fat loss without the need for extreme diets.
🫀 Metabolic and cardiovascular support
The use of Ozempic is often associated with improvements in blood pressure, lipid profile, and inflammatory markers, thereby reducing overall metabolic risk.
How to take Ozempic (Semaglutide)
Semaglutide is supplied in a vial containing 2 mg of lyophilized powder and must be reconstituted with water for injection prior to use.
It is administered via a weekly subcutaneous injection, always on the same day.
Indicative dosage schedule
- Weeks 1–4: 0.25 mg
- Weeks 5–8: 0.5 mg
- Weeks 9–12: 1.0 mg
- Week 13+: up to 2.0 mg (only if necessary and well tolerated)
It is not necessary to increase the dose if the current dose is already effective and well tolerated.
Precautions and side effects
Possible side effects:
- Nausea (more common in the first few weeks)
-
Reduced appetite
-
Bloating or mild digestive discomfort
- Headache or fatigue
Main contraindications:
- Personal or family history of medullary thyroid carcinoma or MEN2 syndrome
- Pregnancy and breastfeeding
- Concomitant use with other GLP-1 agonists (e.g., tirzepatide, retatrutide)
Storage
- Store in the refrigerator at 2–8 °C.
-
Do not freeze
-
Protect from light
- After reconstitution, use within approximately 30 days.














